1d
GlobalData on MSNElixirgen’s gene therapy shows promise in telomere biology disordersEarly results from the company’s single-arm trial saw the therapy able to partially repair the chemical responsible for ...
Children with pediatric-onset multiple sclerosis (POMS) have shorter telomeres, suggesting MS may accelerate biological aging.
The Food and Drug Administration (FDA) has granted Orphan Drug designation to EXG-34217 for the treatment of telomere biology disorders.
Data published in NEJM Evidence detail the first clinical test of ZSCAN4 for telomere elongation.Treatment with EXG-34217 resulted in in vivo ...
A new proteomic aging clock may predict biological age, mortality risk, and the likelihood of age-related diseases, though ...
Keep your body and mind vibrant for decades with these practical daily habits that require no expensive products or complicated regimens.
Telomir Pharmaceuticals (NASDAQ: TELO) announced new preclinical findings demonstrating that its proprietary compound, Telomir-1, fully reverses calc ...
Researchers from Osaka University, Japan claim to have found a cellular 'master switch' which can reverse the process of ...
Based on early Phase I/II data, investigators at Cincinnati Children's are enrolling more patients with a telomere biology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results